Renal Cancer - Results from #5380

The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges January 25, 2017

Basic Parameters of Blood Count as Prognostic Factors for Renal Cell Carcinoma January 25, 2017

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts January 25, 2017

Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma January 25, 2017

Targeting of Tumor Growth and Angiogenesis Underlies the Enhanced Antitumor Activity of Lenvatinib in Combination with Everolimus January 23, 2017

Incidence, clinicopathologic features, and fusion transcript landscape of translocation renal cell carcinomas January 23, 2017

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review January 19, 2017

Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study January 19, 2017

Patterns of Care and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma-Results From a Tertiary Cancer Center in India January 19, 2017

Epigenetic sampling effects: nephrectomy modifies the clear cell renal cell cancer methylome January 18, 2017

Sunitinib stimulates expression of VEGFC by tumor cells and promotes lymphangiogenesis in clear cell renal cell carcinomas January 17, 2017

PD-L1 expression in papillary renal cell carcinoma January 17, 2017

Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience January 17, 2017

Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study January 15, 2017

Inflammatory Myofibroblastic Tumor of the Kidney: A Rare Renal Tumor January 13, 2017

Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma January 13, 2017

Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients January 12, 2017

Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects January 12, 2017

The association between age-related macular degeneration and renal cell carcinoma: a nested case-control study January 12, 2017

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma January 11, 2017

Page 270 of 456